In a 65-year-old woman with reduced left ventricular ejection fraction, which diagnostic test is preferred: invasive coronary angiography or cardiac magnetic resonance imaging?

Cardiac MRI is the preferred initial test in a 65-year-old woman with reduced ejection fraction

In a patient with low ejection fraction of unclear etiology, cardiac MRI should be performed first to distinguish ischemic from non-ischemic cardiomyopathy, assess viability, and quantify scar burden—reserving invasive coronary angiography for cases where revascularization is being considered based on high-risk features or when MRI demonstrates ischemic patterns with viable myocardium. 1

Algorithmic Approach to Testing Selection

Step 1: Initial Noninvasive Assessment

• Cardiac MRI is the Class IIa recommendation for assessing LVEF and volume when echocardiography is inadequate, and it provides superior characterization of myocardial infiltration and scar burden 1
• MRI offers comprehensive evaluation of:
  • Precise LVEF quantification (gold standard)
  • Myocardial viability assessment
  • Scar pattern (ischemic vs. non-ischemic)
  • Infiltrative processes
  • Myocardial fibrosis burden

Step 2: Determine Need for Angiography Based on MRI Findings

Proceed to invasive coronary angiography (Class IIa) when: 1

• MRI demonstrates ischemic scar pattern with viable myocardium that could benefit from revascularization
• Patient has known CAD with symptoms despite optimal medical therapy
• High-risk features are present (extensive ischemia, multivessel disease suspected)
• Patient is a revascularization candidate

Defer angiography when:

• MRI shows non-ischemic cardiomyopathy pattern
• No viable myocardium in ischemic territories
• Patient has significant non-cardiac comorbidities precluding revascularization
• Patient declines revascularization consideration

Key Evidence Supporting This Approach

The 2013 ACC/AHA Heart Failure Guidelines explicitly state that noninvasive imaging to detect myocardial ischemia and viability is reasonable in patients with heart failure and CAD (Class IIa), and that viability assessment is reasonable before revascularization (Class IIa, Level B) 1. Cardiac MRI specifically receives a Class IIa recommendation for assessing myocardial infiltration and scar burden 1.

Recent research confirms that cardiac MRI provides 97% sensitivity for detecting ischemic heart disease and offers comprehensive assessment of LV function, myocardial perfusion, and viability 2. The CAMAREC study design validates MRI's role in differentiating ischemic from non-ischemic cardiomyopathy in reduced LVEF patients 3.

Critical Distinctions Between the Two Tests

Cardiac MRI Advantages:

• Non-invasive with no procedural mortality risk (vs. 0.1% death rate with angiography) 4
• Distinguishes ischemic from non-ischemic patterns
• Quantifies scar burden and viability
• Assesses myocardial infiltration
• No radiation exposure
• Superior tissue characterization

Coronary Angiography Advantages:

• Defines coronary anatomy definitively
• Required before revascularization decisions
• Allows FFR assessment for intermediate lesions
• Enables same-session intervention if appropriate

Common Pitfalls to Avoid

1. Don't perform angiography first without knowing the etiology: You may subject a patient with non-ischemic cardiomyopathy to unnecessary invasive risk (0.1% mortality, 2% non-fatal complications) 4

2. Don't skip viability assessment: Revascularizing non-viable myocardium provides no benefit—MRI identifies this before angiography 1

3. Don't order angiography if the patient isn't a revascularization candidate: Patients with severe non-cardiac comorbidities or those declining intervention should not undergo invasive testing 5

4. Recognize MRI contraindications: Patients with certain implanted devices, severe renal dysfunction (for contrast), or claustrophobia may require alternative strategies

When to Proceed Directly to Angiography

Skip MRI and proceed directly to invasive angiography when: 6, 7

• Patient has high-risk clinical features suggesting left main or multivessel disease requiring urgent revascularization
• Acute decompensated heart failure with suspected acute coronary syndrome
• Life-threatening arrhythmias or resuscitated cardiac arrest
• Patient already has definitive indication for revascularization based on other testing

The Bottom Line

Start with cardiac MRI to characterize the cardiomyopathy, assess viability, and determine if an ischemic pattern exists. This strategy avoids unnecessary invasive procedures in non-ischemic cases while identifying the subset of patients who will actually benefit from angiography and potential revascularization. The composite complication rate of angiography (1-2% major complications, 0.1-0.2% death/MI/stroke) 8 makes it inappropriate as a first-line test when a non-invasive alternative can provide the necessary diagnostic information.